Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)

Clinical trial NCT00086125 · COMPLETED

Trial details

NCT number: NCT00086125
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancies Leukemia Myelodysplastic Syndromes Myeloid Metaplasia Lymphoma

Start date: 2004-06-01
Primary completion: 2006-06-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.